Biodesix
BDSX
$1.25
Share price
0.00%
Change (1 day)
-30.56%
Change (1 year)
Categories
Operating Margin for Biodesix (BDSX)
Operating Margin as of April 2024 (TTM): -150.14%
According to Biodesix's latest financial reports and stock price the company's current Operating Margin is -150.14%. At the end of 2021 the company had an Operating Margin of -79.18%.
Operating Margin history for Biodesix from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -79.18% | 15.07% |
| 2020 | -68.81% | -45.01% |
| 2019 | -125.15% | -2.28% |
| 2018 | -128.06% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 LabCorp LH | 10.63% | -107.08% | 🇺🇸 USA |
 OpGen
OPGN | -1,429.94% | 852.40% | 🇺🇸 USA |
 NeoGenomics
NEO | -31.26% | -79.18% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.